surmount-1 trial tirzepatide obesity without diabetes (ZEPBOUND) Approved for Chronic Weight Management in Adults with ✨ The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or Tirzepatide lowers body weight for

Meet our doctors Last reviewed: 04 Aug 2025 Sources Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison (2022) Diabetes Obesity & Metabolism [accessed 15 June 2025] MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss (2023) Gov.uk [accessed 15 June 2025] Mounjaro (2023) Mounjaro [accessed 15 June 2025] Mounjaro KwikPen 2.5/5/7.5/10/12.5/15 mg solution for injection in pre-filled pen (2024) EMC [accessed 15 June 2025] Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial (2018) The Lancet [accessed 15 June 2025] Weight loss injections NHS weight loss injections GLP-1 for weight loss Can doctors help with weight loss

It essentially quarantines the uncomfortable period to days when you have the most control over your environment

7.1 Mechanisms promoting chemoresistance Recent investigations have progressively identified members of the sirtuin family, notably SIRT1 and SIRT2, as key regulators of multiple adaptive strategies used by tumor cells to avoid chemotherapy-induced lethal effects

If you recently increased your dose, consider waiting until after your trip to adjust further

Final Check: Ensure there are no clumps or particles left before storing the vial in the refrigerator